STAT+: Breast cancer pill from AstraZeneca misses mark in pivotal trial 
STAT News
A pill from AstraZeneca failed to improve outcomes in closely watched breast cancer study, a result that could limit the use of the medicine.
STAT+: Trump’s secretive pharma deals may undermine ‘most-favored nation’ pricing, an analysis suggests
The projected savings from Trump's "most-favored nation" pricing policy might be drastically reduced by secretive deals with pharma companies, a new analysis finds.
STAT+: Scholar Rock wins FDA approval for first drug to target SMA muscle loss STAT News
A late-stage clinical trial found that, when combined with an SMN2-targeting drug, Isembyld caused young patients’ motor skills to improve after a year.
STAT+: Pharma wins a battle over the cost of wastewater treatment in Europe STAT News
An E.U. AG recommended annulling part of a directive that requires drugmakers to finance 80% of the costs of wastewater treatment.
U.S. Officials Announce Cyclospora Outbreak Is Over 
NYT Health
Nearly 13,000 cases of the illness had been linked to lettuce from Taylor Farms that was processed in Mexico. An investigation into how the parasite spread is continuing.
U.S. officials declare an end to record-setting cyclospora outbreak, but its origin is still unknown STAT News
The largest cyclospora food poisoning outbreak in U.S. history is over, U.S. health officials said, but questions remain over its origin.
How Did a Heart Drug With So Much Promise Fall So Flat? NYT Health
Cardiologists are struggling to figure out why a drug that should have prevented heart attacks didn’t work at all.
STAT+: Up and down the ladder: The latest comings and goings STAT News
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Medicaid will let states use ‘tiers’ to determine medical frailty STAT News
New Medicaid rules use allow use of tiers to determine work exemptions. Advocates fear complex guidelines could cause patients to lose insurance.
STAT+: Pharmalittle: We’re reading about anxious Novartis investors, patent expirations for biologics, and more STAT News
Novartis investors are stepping up scrutiny of the company's dealmaking after setbacks to drugs it acquired through mergers and acquisitions
STAT+: Cancer drug shortages keep disrupting patient care STAT News
Platinum chemotherapy's long-term effects, surprising heart failure drug failures, and more biotech news from The Readout
Too much light at night may quietly reshape your heart 
ScienceDaily Health
Nighttime light exposure was linked to thicker, stiffer heart chambers and early signs of reduced heart function in a study of more than 11,000 people. The findings suggest that keeping bedrooms darker could be an overlooked strategy for protecting the heart.
Boycott launched against American Diabetes Association includes journal STAT News
Trump's $500 Obamacare promise, childhood cancer treatment with long-term risks, and more health news
Opinion: I’m a public health communications consultant. Pro-vaccine advocacy needs more fun STAT News
“Somewhere along the way, we forgot how to celebrate vaccines,” writes public health communications consultant Adam Zimmerman.
Opinion: I’m a thoracic surgeon in New York City. For many of my patients, Sept. 11 is still not over STAT News
“For thousands of families, the Sept. 11 attack did not end when the fires were extinguished. It simply changed form,” writes Raja Flores.
STAT+: An AI tool aims to catch harder-to-detect heart attacks in EKGs STAT News
A newly approved AI tool can scan EKGs for severe heart attacks and, the company says, for rarer patterns indicating blocked arteries.
STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field STAT News
The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines. They could also have a chilling effect across the industry.
No matching stories
Try another keyword or clear the search box.
